4//SEC Filing
Manion Douglas J. 4
Accession 0001209191-22-043928
CIK 0001557746other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:10 PM ET
Size
8.0 KB
Accession
0001209191-22-043928
Insider Transaction Report
Form 4
Manion Douglas J.
Pres and COO
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-08-01+217,800→ 217,800 totalExercise: $13.62Exp: 2032-07-31→ Common Stock (217,800 underlying) - Award
Restricted Stock Units
2022-08-01+62,300→ 62,300 total→ Common Stock (62,300 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on August 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F3]The shares underlying these restricted stock units vest in four equal annual installments beginning on August 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001875875
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:10 PM ET
- Size
- 8.0 KB